Advertisement
UK markets closed
  • NIKKEI 225

    38,920.26
    +534.53 (+1.39%)
     
  • HANG SENG

    19,376.53
    +302.82 (+1.59%)
     
  • CRUDE OIL

    79.35
    +0.72 (+0.92%)
     
  • GOLD FUTURES

    2,384.40
    -10.50 (-0.44%)
     
  • DOW

    39,966.67
    +58.67 (+0.15%)
     
  • Bitcoin GBP

    51,374.21
    -520.43 (-1.00%)
     
  • CMC Crypto 200

    1,372.17
    -21.87 (-1.57%)
     
  • NASDAQ Composite

    16,740.53
    -1.87 (-0.01%)
     
  • UK FTSE All Share

    4,594.70
    -2.01 (-0.04%)
     

Syra Health Corp. Class A Common Stock (NASDAQ:SYRA) Q4 2023 Earnings Call Transcript

Syra Health Corp. Class A Common Stock (NASDAQ:SYRA) Q4 2023 Earnings Call Transcript March 25, 2024

Syra Health Corp. Class A Common Stock isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good morning, ladies and gentlemen, and welcome to Syra Health Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all lines are in a listen-only mode. [Operator Instructions] This call is being recorded on Monday, March 25, 2024. I would now like to turn the conference over to Ben Shamsian. Please go ahead.

Ben Shamsian: Good morning, everyone, and thank you for joining us for Syra Health's fourth quarter and full year 2023 financial results conference call. Joining us on the call is Dr. Deepika Vuppalanchi, CEO of Syra Health; Syra Health's Executive Chairman and President, Sandeep Allam; and Priya Prasad, Syra’s Chief Financial Officer. At the conclusion of today's prepared remarks, management will answer some questions that were sent to us by investors and other questions we think are relevant to investors as well. Today's event is being recorded and will be available for replay through the webcast information provided in the press release. Finally, I'd also like to call your attention to the customary safe harbor disclosures regarding forward-looking information.

ADVERTISEMENT

The conference call today will contain certain forward-looking statements, including statements regarding the goals, strategies, beliefs, expectations, and future potential operating results of Syra Health. Although management believes that these statements are reasonable based on estimates, assumptions, and projections as of today, these statements are not guarantee of future [Technical Difficulty] Time sensitive information may no longer be accurate at any time telephonic webcast replay. Actual results may differ materially as a result of risks, uncertainties, and other factors including, but not limited to, the factors set forth in the company's filings with the SEC. Syra undertakes no obligation to update or revise any of these forward-looking statements.

With that said, I would like to turn the event over to Dr. Deepika Vuppalanchi, Chief Executive Officer of Syra Health. Deepika, please proceed.

5 States With the Healthiest Populations
5 States With the Healthiest Populations

A healthcare professional wearing a health communications device discussing patient data with a colleague.

Deepika Vuppalanchi: Thank you, Ben, and welcome, everyone. I'm pleased to discuss with you our 2023 financial results and our 2024 outlook. 2023 was a transformational year for Syra Health as we successfully completed our initial public offering and began trading on the NASDAQ. This is an exciting time for Syra Health as we embark on fulfilling our promise to continually push the boundaries of mental health solutions, explore new frontiers in digital health, and remain dedicated to our pursuit of a healthier population. Our goal is to become a leader in healthcare solutions for our partners and expand our operations by leveraging our established success, which we have achieved in key geographical areas to drive growth nationwide.

See also 20 Biggest Health Care Companies in Australia, 2024 and 32 Countries with the Highest Rates of Diabetes.

To continue reading the Q&A session, please click here.